Yenikomshian, MBA MA, White, PhD AG, Carson, BS ME, Garrison, PhD LP, Oderda, PharmD, MPH GM, Biskupiak, PhD, MBA JE, Hlavacek, MPH PR, Roland, PharmD, MS CL. Projecting the cost, utilization, and patient care impact of prescribing extended release non-abuse-deterrent opioids to chronic pain patients. J of Opioid Management [Internet]. 2017 Sep. 1 [cited 2024 Nov. 24];13(5):291-30. Available from: https://wmpllc.org/ojs/index.php/jom/article/view/734